CompletedPhase 1

AutoVPAP Versus VPAP; Assessment of Sleep and Ventilation

United Kingdom20 participantsStarted 2005-11

Plain-language summary

The aim of the study is to compare the effects of a modified form (AutoVPAP) of the VPAP non-invasive ventilator versus standard VPAP ventilation on sleep quality and breathing during sleep in stable patients with nocturnal hypoventilation due to restrictive ventilatory disorders (eg. neuromuscular disease or chest wall disorder).

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18-80 years * Nocturnal hypoventilation (nocturnal peak transcutaneous PCO2 \> 6.5 kPa when breathing spontaneously) with * Congenital neuromuscular disease (eg. Duchenne muscular dystrophy, congenital muscular dystrophy), acquired neuromuscular disease (eg. old polio, bilateral diaphragm paralysis) or chest wall disease (eg. idiopathic scoliosis, thoracoplasty) * Recruited from 1300 patients attending Royal Brompton Hospital Lind ward ventilator clinic. * All patients will be familiar with non-invasive ventilation use but currently using a ventilator which is not a VPAP model eg. BiPAP Harmony, Breas PV403. * Able to understand treatment and protocol Exclusion Criteria: * Unstable respiratory failure (PaO2 \< 7.5 kPa, PaCO2 \> 8.0 kPa, * Uncontrolled heart failure or arrhythmia * Moderate or severe bulbar weakness. * Unable to understand treatment or protocol

What they're measuring

Compare objective measures of sleep, sleep related ventilation and daytime respiratory function between the two treatment devices, VPAP and AutoVPAP.

Trial details

NCT IDNCT00252252

SponsorResMed

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2007-06

View on ClinicalTrials.gov More Chest Wall Disorder trials